Funder: National Institutes of Health
Due Dates: April 7, 2025 (earliest submission) | May 7, 2025 | January 7, 2026 | May 7, 2026
Funding Amounts: Up to $400,000/year in direct costs, max 4 years per project (R01 mechanism).
Summary: Supports research to elucidate mechanisms of early immune system development in utero, post-natal, and early childhood, especially in the context of HIV and antiretroviral exposure.
Key Information: Clinical trials are optional; broad eligibility including foreign organizations and multiple institution types.